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Summal'y 
Previous T  cell receptor (TCR)  sequence analysis  of a panel of 23  H-2K  d restricted cytotoxic 
T lymphocyte (CTL) clones recognizing the decapeptide HLA-CW3 170-179 revealed a striking 
conservation of TCR structure, in that all clones examined used V310 and Jcz pHDS58 segments. 
We show here that the primary response in vivo after intraperitoneal injection of DBA/2 mice 
with HLA-CW3 expressing transfectants of syngeneic P815 (H-2  d) tumor cells is characterized 
by a dramatic expansion of CD8 + V/810  + CTL in the peritoneal cavity and draining (mesenteric) 
lymph node, as well as in peripheral blood. Additional analysis of TCR on HLA-CW3 immune 
populations by flow cytometry and polymerase chain reaction further indicates that the vast majority 
of responding CD8 + cells express restricted Vc~ domains, a dominant Jc~ segment (pHDS58), 
and a conserved CDR3 length for both c~ and/8 chains. This novel system provides a unique 
opportunity to directly monitor an oligoclonal primary antigen specific immune response in 
vivo at the single cell level independently of functional assays. 
T 
he TCR-otl/8 on CD4 § and CD8 § T  cells recognizes 
processed peptides bound to MHC class II or I mole- 
cules,  respectively.  TCR repertoire diversity is determined 
by the number of distinct gene segments encoding variable 
(V, D, and J) elements of the ot and/8 chains as well as by 
N-nucleotide additions that occur during somatic recombi- 
nation. Although it is generally accepted that variable com- 
ponents  of both  TCR  ot  and/8  chains contribute to  the 
specificity of recognition of a given peptide-MHC complex, 
there are many documented cases in which preferences for 
certain TCR gene elements occur (1). A  striking example 
of TCR preference concerns the recognition of the decapep- 
tide HLA-CW3 170-179 in association with H-2K  d. In this 
system, 23 independent CD8 ~ CTL dones were all found 
to use the V/810 domain and a unique Jo~ segment (2).  Fur- 
thermore, CD8 + peritoneal exudate lymphocytes (PEL) re- 
covered from the site of secondary rejection of syngeneic tumor 
cell transfectants expressing HLA-CW3 were highly enriched 
in V310 + cells  (2).  These findings prompted us to inves- 
tigate whether the primary in vivo immune response to this 
peptide antigen could be followed directly by flow cytometric 
1  The first two authors made equivalent contributions to this work. 
analysis of CD8 § V/810 + cells.  We show here that CD8 + 
V/810 §  cells increase dramatically in the lymphoid tissues 
and blood of DBA/2 mice during the course of a primary 
immune response to syngeneic P815 tumor cells transfected 
with  the HLA-CW3  gene.  This  novel system provides  a 
powerful tool  to  investigate many quantitative  aspects  of 
antigen-specific in vivo immune responses independently of 
functional assays. 
Materials and Methods 
Immunization.  Adult female DBA/2 mice (Harlan Olac Ltd., 
Bicester, UK) were injected intraperitoneally with lff viable P815 
tumor cells transfected  with the HLA-CW3 gene (3). At various 
times thereafter, animals were bled and/or killed. PBL were purified 
by Ficoli-Hypaque centrifugation and PEL by nylon wool columns. 
Single cell suspensions  of inguinal, axillary, or mesenteric lymph 
nodes and spleen were prepared by standard procedures. 
mAbs andFlow Cytometry.  The following mAbs were used: GK- 
1.5 (anti-CD4); 53-6-7 (anti-CDS); B21.5 (anti-VB10; 4); B21.14 
(anti-Vow8; 4); KTS0 (anti-Vc~8; 5); and B20.1 (anti-Vcr  6). For 
most  experiments,  triple  staining  was  performed with  FITC- 
conjugated anti-CDS, PE-conjugated anti-CD4, and biotinylated 
anti-V/~10 (revealed with avidin-tricolor). The anti-Vo~ mAbs were 
revealed by FITC-conjugated goat anti-rat Ig (Ca/tag Laborato- 
ties, San Francisco, CA), and triple staining was completed with 
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tricolor).  Samples were analyzed on a FACScan |  (Becton Dick- 
inson & Co., Mountain View, CA) equipped with LYSIS II software. 
For cell sorting experiments, immune (day 12) PBL or PEL were 
double stained with FITC-conjugated anti-CD8 and biotinylated 
anti-V~10  (revealed  with  avidin-tricolor).  CD8*  V~10 +  and 
CD8 + V310-  cells  were sorted  on  a FACStar  PLUS  |  (Becton 
Dickinson & Co.) and tested for cytolytic activity after overnight 
incubation  at 37~  (to allow reexpression of modulated TCR). 
Cytolytic  Assay.  P815-CW3  transfectants  and  control  P815 
tumor cells were labeled with StCr as described  (3). 2  x  103 SlCr- 
labeled target cells were mixed with varying numbers of sorted 
effector cells in V-bottomed microplates. S*Cr-release in superna- 
tants was quantitated  after 3.5  h. 
cDNA-PCR and Direct Sequencing.  RNA extraction,  cDNA syn- 
thesis, and PCR using Vc~8, V310, Cc~, and C3 primers were car- 
ried out on CTL clones and freshly isolated PBL or PEL as previ- 
ously described (2, 7). Direct sequencing of the PCR products was 
as described (8). 
Results  and  Discussion 
We have recently shown that a large panel of independent 
CD8 + CTL clones recognizing  the peptide CW3  170-179 
in association with H-2K  a utilize exclusively the TCR VB10 
domain (2). This surprising result prompted us to examine 
the  TCR  V3  usage  of CD8 +  T  cells  during  a  primary 
response to this  antigen  in vivo. For this purpose,  DBA/2 
(H-2  d) mice were injected intraperitoneally with viable syn- 
geneic P815  mastocytoma cells transfected  with  the HLA- 
CW3 gene. Previous studies have shown that such P815-CW3 
transfectants  are normally rejected by DBA/2  mice within 
10-12  d  and  that  CD8 +  CTL  clones  specific  for  CW3 
170-179 can be derived from such an immunization protocol 
(3,  9). 
As shown in Fig.  1, PBL from DBA/2  mice taken  10 d 
after injection  of 107 P815-CW3  transfectants  contained  a 
very  high  proportion  (,'o65%)  of CD8 +  Vfll0 +  cells,  as 
compared with PBL from control mice (7% CD8 + V310+). 
This enrichment of V310 + cells occurred only in the CD8 + 
subset since CD4 § V310 § PBL from immune mice remained 
at the same level (,o10%) as in unimmunized controls. Anal- 
ysis of various tissues at day 10 after immunization  further 
indicated that CD8 + Vfll0 § cells were specifically elevated 
not  only in blood but  also in the peritoneal cavity, spleen, 
and draining (mesenteric) lymph node (Table 1). In contrast, 
no  increase in  CD8 §  VBI0 +  cells was  seen  in distant  (ei- 
Table  1.  Expression of V~IO by CD4*  or CD8 + Cells from Different  Tissues of P815-CW3 Immune DBA/2  Mice 
Normal  Immune 
Cell  source  CD4  CD8  CD4  CD8 
Spleen  11.1  +  0.9  9.0  +  0.6  9.9  _+  0.4  41.5  _+  3.2 
Mesenteric LN  11.5  _+  0.2  9.2  _+  0.3  11.1  _+  0.5  26.0  +_  4.5 
Axillary LN  11.4  +  0.1  9.0  +  0.5  11.3  _+  0.5  11.9  +  1.1 
PBL  11.8  +_  0.3  10.4  _+  2.1  10.7  +  0.4  62.1  +_  4.3 
PEL  (-)*  (-)*  9.5  _+  2.1  86.1  +  4.2 
The indicated cell populations from normal or day 10 immune mice were triple stained as in Fig.  1. Data are expressed as percent VB10  § cells 
(mean  +  SD of three mice) within  the CD4 + or CDS+ subset. 
* PEL could not be recovered in sufficient numbers from uninjected mice for further  analysis. 
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Figure  1.  Expression of VB10 by PBL from normal and 
P815-CW3 immune (day 10) DBA/2 mice. Cells were triple 
stained with mAbs against CD4, CDS, and V/~10. Cytograms 
represent CD4/CD8 staining of total PBL, whereas histo- 
grams represent VBIO staining gated on CD4 + or CD8" 
cells, respectively. 
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Figure  2.  Kinetics and tissue distribution  of CD8 + VB10  § cells in 
P815-CW3 immune mice. Cells from the indicated tissues were triple stained 
as in Fig. 1. Data are plotted as percent VB10  § cells (mean _+ SD) gated 
on the CD8 § subset. (---) Mean of CD8 + VB10  § cells in the corre- 
sponding tissue from control (uninjected) DBA/2 mice. No change in per- 
cent CD4 + VB10  + cells was observed in any tissue or at any time (data 
not shown). 
ther axillary or inguinal) lymph nodes (Table 1). Kinetic studies 
(Fig.  2) demonstrated  that increases in CD8 + VB10 + cells 
first could be detected in blood after 6 d and persisted at high 
levels for at least  5  wk  after immunization. 
To further define the correlation between expression of V~10 
and specificity for HLA-CW3  in vivo, CD8 + PEL or PBL 
from DBA/2 mice that had rejected P815-CW3 transfectants 
were sorted on the basis of V~10 expression (Fig. 1) and sub- 
sequently tested for cytolytic activity on P815-CW3 or con- 
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Figure  3.  Cytolytic activity of HLA-CW3 immune (day 12) PBL (circles) 
and PEL (t~ngles) expressing VB10. Sorted CD8 § VEt0 + (solid symbols) 
and CD8 + VB10- (open symbols) cells were assayed for cytolytic activity 
on HLA-CW3 transfected P815 target cells at the indicated E/T ratios. 
No lysis of untransfected P815 target calls was observed (data not shown). 
trol P815 target cells. As shown in Fig. 3, HLA-CW3 specific 
CTL activity was only detected in the CD8 + VB10 + popu- 
lations,  indicating  that  few  (if any)  VB10-  specific  CTL 
were  generated  during  the  immunization  procedure.  This 
finding demonstrates  dearly that  the unique  VBIO expres- 
sion  observed  among  23  CTL  clones  characterized  in  our 
previous study (2) did not reflect any bias introduced by in 
vitro cloning. 
Studies  with  HLA-CW3  specific CTL clones have indi- 
cated a striking conservation of other structural  features of 
the TCR in addition to V~10 usage (2). For example, a large 
proportion of clones (8 of 23) utilized members of the Vol8 
CD8+VI~I0  +  CD8+VIsI0" 
2.7  1.7 
v~z 
14.2  ~i  ~  2.4 
v~s 
Figure  4.  TCR VQ expression by CD8 + V~10  § cells from P815-CW3 
immune DBA/2 mice. PEL from day 12 immune mice were triple stained 
with mAbs against CD8, VB10, and Va8 or Vow2. Histograms represent 
V~  staining gated on  CD8 §  VjS10  §  or CD8 §  VBI0-  populations. 
Similar results were obtained with two independent mAbs against VQ8 
(KT50 or B21.14). 
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segment (p71). We therefore stained P815-CW3 immune PEL 
or PBL with mAbs B21.14 (4) or KT50 (5), both of which 
recognize Vot8-expressing  T  ceils.  Approximately  15%  of 
CD8 + VB10 + cells from day 12 immune mice were stained 
with either of these mAbs, as compared with 3-4% in con- 
trol DBA/2 mice (Fig. 4 and data not shown).  In contrast, 
Vot2  expression  was  much  lower  among  day  12  immune 
CD8 + VB10 + ceils  than  in  normal  DBA/2  controls  (Fig. 
4 and data not shown). These data emphasize the restricted 
Vot  repertoire  of P815-CW3  reactive  CD8 +  T  cells  and 
again concur with previous estimates of Vot usage in our panel 
of CTL  clones. 
In addition to V domain preferences, other structural fea- 
tures of the TCR were highly conserved in our panel of HLA- 
CW3 specific CTL clones. In particular,  all clones examined 
used theJc~ pHDS58 segment and both ot and/3 chains showed 
a highly conserved length of the CDR3 domain (2). To de- 
termine whether  such features also applied to the TCR of 
CD8 + cells generated in a primary response in vivo to PS15- 
CW3 transfectants, we performed direct sequencing of PCR 
amplified cDNA obtained from immune PBL and PEL popu- 
lations. 
To examine directly the B chain junctional region, a com- 
bination of V~10 and C~/primers was used to amplify cDNA 
from day 10 PBL and PEL. The PCR products were directly 
sequenced with a second antisense CB primer located close 
to the VDJCjunction (Fig. 5 A). As expected, the sequencing 
reaction  was essentially unreadable  through  the junctional 
region (with the exception of two successive guanine nucleo- 
tides encoding a conserved glycine residue at position  97). 
However, the sequence of VB10 was clearly readable, indi- 
cating  that  most Vfll0-bearing  cDNAs from the immune 
PBL or PEL populations had the same junctional length en- 
coding six amino acids in the CDR3 loop. This nucleotide 
structure is identical to that found in fl chains of CTL clones 
reactive with  HLA-CW3  (2 and Fig.  5 A).  The  sequence 
of Vfll0-Cfl  PCR products  obtained  from  control  unim- 
munized DBA/2 PBL was not readable in either  the junc- 
tional  or VfllO region  (Fig.  5 A). 
To analyze the TCR c~ chain structure of day 10 immune 
PBL or PEL,  a combination  of Vot8 and Cot primers  was 
used. Sequencing of the PCR products was performed with 
a second Cot primer located close to the VJC junction (Fig. 
5 B). Remarkably, the Jot pHDS58 sequence was clearly read- 
able in the day 10 PEL and,  to a lesser extent, PBL popula- 
tions.  Furthermore,  after a short  unreadable  stretch  corre- 
sponding  to  the  VJ junction,  the  Vot8  sequence was  also 
readable.  These  data  demonstrate  that  most  VotS-bearing 
cDNAs in the immune PBL or PEL populations have a con- 
served CDR3  loop of nine  amino  acids  incorporating  the 
Jot pHDS58 sequence. Again, this nucleotide structure is iden- 
tical to that found in Vcc8-bearing HLA-CW3 specific CTL 
clones (2 and Fig, 5 B). No readable sequence was obtained 
when the same Vot8 and Cot primers were used to amplify 
cDNA for unimmunized DBA/2 PBL (Fig. 5 B). Taken  to- 
gether,  the results indicate  that  the primary CD8 + T  cell 
response to HLA-CW3 transfectants in vivo is highly oligo- 
clonal and that the TCR structure of most responding cells 
is identical to that described previously for established CTL 
clones with  the  same antigen  specificity. 
The observed increases in CD8 + VfllO + cells after immu- 
nization with P815-CW3 transfectants are even more striking 
when expressed in terms of absolute cell numbers.  As illus- 
Figure  5.  Limited  heterogeneity 
of TCR ~ and B chains expressed 
by freshly isolated HLA-CW3  im- 
mune PBL or PEL. cDNA isolated 
from normal PBL or from day 10 
immune PBL or PEL populations 
was amplified  with either Vfll0-CB 
(A) or Va8-Cot (/3) primers. The 
PCK products were then directly 
sequenced with nested Cfl  and 
Ca primers, respectively.  (Arrows) 
Direction of sequencing. The auto- 
radiogram is shown backwards to 
allow reading of the coding strand 
from top to bottom in the GATC 
order (left to right).  The  HLA- 
CW3 specific  CTL clones used as 
a positive control were CW3/1.1 
and  CW3/Cas20  in  A  and  B, 
respectively (2). 
1490  Flow Cytometric and PCR. Analyses of a Primary T Cell Response In Vivo Table  2.  Increase in Absolute Numbers of CD8 + V~IO + Cells after P815-CW3 Immunization 
Total CD8 + V/~10  + 
Mice  Cell source  Cells (x  106)  Percent CD8 §  Percent V/310  + in CD8  (x  106) 
Control  PBL  0.59  _+  0.07  5.8  _+  0.7  10.4  _+  2.1  0.0036  +  0.0011 
Immune  PBL  1.53  _+  0.20  31.1  _+  3.1  62.1  +  4.2  0.29  +_  0.04 
Control  Spleen  87  +_  8  2.5  _+ 0.4  9.0  _+  0.6  0.19  _+  0.03 
Immune  Spleen  284  +_  44  5.3  _+  0.7  41.5  +_  3.2  6.3  +_  1.8 
Data are mean _+ SD of three individual control or day 10 immune DBA/2 mice. PBL values are calculated for 1 ml of whole blood (after FicoU- 
Hypaque centrifugation). 
trated in Table 2, CD8 + VB10 + cells increased about 80-fold 
in blood and 30-fold in spleen 10 d after immunization. Taking 
into account that the responding cells used highly restricted 
Vc~ domains, a predominant (or perhaps unique) Joz segment 
and a highly conserved CDR3 length for both ot and/~ chains 
(see above), it is likely that they represent only a very small 
fraction of the CD8 + VBIO §  subset.  The precise number 
of cells expressing such TCR in unimmunized mice is difficult 
to  estimate  and  could  theoretically be  biased  during  se- 
lection of the T  cell repertoire in  the thymus.  However, 
assuming random usage  of Vcz  and Jc~ segments  and ex- 
trapolating from the limited data available on CDR3 length 
(10), it is likely that at most only ~1:104 CD8 + V~10 + cells 
bear a TCR clonotype incorporating structural features neces- 
sary to respond to CW3 170-179 in association  with H-2K  d. 
If true, this estimate implies an "~,106-fold increase in such 
cells (corresponding to a minimum of 20 cell divisions) during 
the  10 d  immunization  period.  In  this  context,  previous 
conclusions regarding the contribution of cell division to 
CD8 +  CTL  responses  to  allografts  in  vivo  have  been 
conflicting (11, 12). 
The sustained increase in oligoclonal CD8 + VB10 + cells 
observed here during the primary response to HLA-CW3 
transfectants is in marked contrast to recent studies of the 
T cell response in vivo to bacterial or retroviral superantigens. 
In the latter case, a limited proliferation of polyclonal VB" 
restricted superantigen-reactive T  cells occurs, but this ini- 
tial expansion phase is followed by the death of the majority 
of the reactive T  cells  in both CD4 +  and CD8 +  subsets 
(13-15). It will be of considerable interest to compare other 
physiological parameters of VB-restricted T cells involved in 
primary responses to peptide antigens and superantigens. 
To our knowledge, the data documented in this report rep- 
resent the first instance in which it has been possible to directly 
quantitate a primary peptide antigen specific T cell response 
in vivo at the single cell level independently of functional 
assays. This unique model system should allow a detailed anal- 
ysis of the cellular requirements of such a response, as well 
as new insights into poorly understood areas such as T  cell 
activation, recirculation, and memory. 
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